ZereneX promotes more than 300 target-focussed libraries as well as small molecule screening libraries for high-throughput screening and fragment-based research. Our focused compound libraries comprise collections of compounds with in silico predicted affinity to a target protein or predicted biological activity.
• Disease-Based Libraries - Alzheimer's disease, diabetes, cancer
• Phenotypic Screening Library
• RNA Binding
• Epigenetic Targets
• Protein-Protein Interaction
• Peptidomimetics
• Glycomimetics
• Protein Kinases
• Proteases
• GPCRs
• Nuclear Receptors
• Ion Channels
• Fragment Libraries
• General Activities
For further details please contact us at enquiries@zerenex-molecular.com
Trial explores potential of therapy in treating multiple cancer types.
Read More >
Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >